急性卒中患者头部体位的集群随机交叉试验
该研究为在九个国家开展的实用性集群随机交叉试验,纳入11,093例急性卒中患者(85%为缺血性卒中),按入院医院随机分配至平卧组或床头抬高至少30度坐位组,指定体位在入院后尽快开始并维持24小时。主要终点为90天改良Rankin量表评估的残疾程度。结果显示两组90天残疾分布无显著差异(未调整OR 1.01,95%CI 0.92–1.10,P=0.84),90天死亡率平卧组7.3% vs 坐位组7.4%(P=0.83),包括肺炎在内的严重不良事件率无显著组间差异。结论认为急性卒中后24小时平卧与床头抬高至少30度坐位的残疾结局无显著差异。
要点
- 急性卒中患者入院后24小时平卧与床头抬高至少30度坐位相比,90天改良Rankin量表残疾分布无显著差异(未调整OR 1.01,95%CI 0.92–1.10,P=0.84)。
- 90天死亡率平卧组7.3% vs 坐位组7.4%(P=0.83),无显著差异。
- 包括肺炎在内的严重不良事件率两组无显著差异。
- 平卧组能维持体位24小时的比例低于坐位组(87% vs 95%,P<0.001)。
- 从卒中症状发作到开始指定体位的中位时间为14小时(四分位距5–35)。
适用人群与场景
- 急性卒中患者,共11,093例,其中85%为缺血性卒中,来自九个国家。
- 指定体位在入院后尽快开始并维持24小时。
处置流程与药物剂量
- 平卧组:完全平卧,背部水平、面部朝上,入院后尽快开始并维持24小时。
- 坐位组:床头抬高至少30度坐位,入院后尽快开始并维持24小时。
研究设计与关键结果
- 研究类型:实用性集群随机交叉试验,九个国家,11,093例急性卒中患者(85%缺血性卒中)。
- 干预与对照:平卧组 vs 床头抬高至少30度坐位组,体位在入院后尽快开始并维持24小时。
- 主要终点:90天改良Rankin量表残疾分布,平卧组 vs 坐位组未调整OR 1.01(95%CI 0.92–1.10,P=0.84),无显著差异。
- 次要终点:90天死亡率平卧组7.3% vs 坐位组7.4%(P=0.83),无显著差异。
- 不良事件:包括肺炎在内的严重不良事件率两组无显著差异。
- 体位维持:平卧组维持24小时的比例87% vs 坐位组95%(P<0.001),平卧组较低。
- 时间指标:卒中症状发作到开始指定体位的中位时间14小时(四分位距5–35)。
证据类型、等级与局限
- 证据类型:实用性集群随机交叉试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急性卒中患者入院后24小时内,平卧与床头抬高至少30度坐位在90天残疾结局上无显著差异,两种体位均可按原文方案实施。
- 平卧体位维持24小时的可行性低于坐位(87% vs 95%),临床中需考虑患者能否耐受平卧。
- 包括肺炎在内的严重不良事件率两组无显著差异,体位选择无需因肺炎风险而倾向某一方案。
指南或共识出处
- HeadPoST试验,ClinicalTrials.gov注册号NCT02162017,由澳大利亚国家健康与医学研究委员会资助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The role of supine positioning after acute stroke in improving cerebral blood flow and the countervailing risk of aspiration pneumonia have led to variation in head positioning in clinical practice. We wanted to determine whether outcomes in patients with acute ischemic stroke could be improved by positioning the patient to be lying flat (i.e., fully supine with the back horizontal and the face upwards) during treatment to increase cerebral perfusion.
METHODS: In a pragmatic, cluster-randomized, crossover trial conducted in nine countries, we assigned 11,093 patients with acute stroke (85% of the strokes were ischemic) to receive care in either a lying-flat position or a sitting-up position with the head elevated to at least 30 degrees, according to the randomization assignment of the hospital to which they were admitted; the designated position was initiated soon after hospital admission and was maintained for 24 hours. The primary outcome was degree of disability at 90 days, as assessed with the use of the modified Rankin scale (scores range from 0 to 6, with higher scores indicating greater disability and a score of 6 indicating death).
RESULTS: The median interval between the onset of stroke symptoms and the initiation of the assigned position was 14 hours (interquartile range, 5 to 35). Patients in the lying-flat group were less likely than patients in the sitting-up group to maintain the position for 24 hours (87% vs. 95%, P<0.001). In a proportional-odds model, there was no significant shift in the distribution of 90-day disability outcomes on the global modified Rankin scale between patients in the lying-flat group and patients in the sitting-up group (unadjusted odds ratio for a difference in the distribution of scores on the modified Rankin scale in the lying-flat group, 1.01; 95% confidence interval, 0.92 to 1.10; P=0.84). Mortality within 90 days was 7.3% among the patients in the lying-flat group and 7.4% among the patients in the sitting-up group (P=0.83). There were no significant between-group differences in the rates of serious adverse events, including pneumonia.
CONCLUSIONS: Disability outcomes after acute stroke did not differ significantly between patients assigned to a lying-flat position for 24 hours and patients assigned to a sitting-up position with the head elevated to at least 30 degrees for 24 hours. (Funded by the National Health and Medical Research Council of Australia; HeadPoST ClinicalTrials.gov number, NCT02162017 .).
参考来源
- Anderson CS, Arima H, Lavados P, et al. Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke. N Engl J Med. 2017. PMID: 28636854. doi:10.1056/NEJMoa1615715
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。